nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—chronic kidney failure	0.807	1	CbGaD
Tyloxapol—LPL—parathyroid gland—chronic kidney failure	0.021	0.35	CbGeAlD
Tyloxapol—LPL—Composition of Lipid Particles—LCAT—chronic kidney failure	0.0116	0.0872	CbGpPWpGaD
Tyloxapol—LPL—blood plasma—chronic kidney failure	0.00858	0.143	CbGeAlD
Tyloxapol—LPL—Fatty Acid Beta Oxidation—ACAT1—chronic kidney failure	0.0054	0.0405	CbGpPWpGaD
Tyloxapol—LPL—Lipoprotein metabolism—ABCG1—chronic kidney failure	0.00472	0.0354	CbGpPWpGaD
Tyloxapol—LPL—Statin Pathway—LCAT—chronic kidney failure	0.00456	0.0342	CbGpPWpGaD
Tyloxapol—LPL—Chylomicron-mediated lipid transport—LIPC—chronic kidney failure	0.00448	0.0336	CbGpPWpGaD
Tyloxapol—LPL—Lipoprotein metabolism—LCAT—chronic kidney failure	0.00444	0.0333	CbGpPWpGaD
Tyloxapol—LPL—nephron tubule—chronic kidney failure	0.00442	0.0736	CbGeAlD
Tyloxapol—LPL—renal system—chronic kidney failure	0.00402	0.0669	CbGeAlD
Tyloxapol—LPL—cardiovascular system—chronic kidney failure	0.00397	0.0661	CbGeAlD
Tyloxapol—LPL—urethra—chronic kidney failure	0.00395	0.0657	CbGeAlD
Tyloxapol—LPL—kidney—chronic kidney failure	0.00389	0.0647	CbGeAlD
Tyloxapol—LPL—cortex of kidney—chronic kidney failure	0.00379	0.063	CbGeAlD
Tyloxapol—LPL—Triacylglyceride Synthesis—LIPC—chronic kidney failure	0.0034	0.0255	CbGpPWpGaD
Tyloxapol—LPL—digestive system—chronic kidney failure	0.0033	0.0549	CbGeAlD
Tyloxapol—LPL—blood—chronic kidney failure	0.00314	0.0523	CbGeAlD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—ABCG1—chronic kidney failure	0.00314	0.0235	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—LCAT—chronic kidney failure	0.00295	0.0221	CbGpPWpGaD
Tyloxapol—LPL—Statin Pathway—LIPC—chronic kidney failure	0.00292	0.0219	CbGpPWpGaD
Tyloxapol—LPL—Lipoprotein metabolism—LIPC—chronic kidney failure	0.00284	0.0213	CbGpPWpGaD
Tyloxapol—LPL—Statin Pathway—SCARB1—chronic kidney failure	0.0027	0.0202	CbGpPWpGaD
Tyloxapol—LPL—Retinoid metabolism and transport—LRP2—chronic kidney failure	0.00267	0.02	CbGpPWpGaD
Tyloxapol—LPL—Fatty Acid Beta Oxidation—CPT1A—chronic kidney failure	0.00264	0.0198	CbGpPWpGaD
Tyloxapol—LPL—Lipoprotein metabolism—SCARB1—chronic kidney failure	0.00262	0.0197	CbGpPWpGaD
Tyloxapol—LPL—Fatty Acid Beta Oxidation—LIPC—chronic kidney failure	0.00257	0.0193	CbGpPWpGaD
Tyloxapol—LPL—Statin Pathway—HMGCR—chronic kidney failure	0.00255	0.0191	CbGpPWpGaD
Tyloxapol—LPL—Statin Pathway—ABCA1—chronic kidney failure	0.00227	0.017	CbGpPWpGaD
Tyloxapol—LPL—Lipoprotein metabolism—ABCA1—chronic kidney failure	0.00221	0.0166	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—PRKAG2—chronic kidney failure	0.00203	0.0152	CbGpPWpGaD
Tyloxapol—LPL—Vitamin A and Carotenoid Metabolism—SCARB1—chronic kidney failure	0.00197	0.0148	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—SREBF2—chronic kidney failure	0.0019	0.0143	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—LIPC—chronic kidney failure	0.00189	0.0142	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—RETN—chronic kidney failure	0.00185	0.0139	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—LPIN1—chronic kidney failure	0.0018	0.0135	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—SCARB1—chronic kidney failure	0.00174	0.0131	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—SREBF2—chronic kidney failure	0.00174	0.0131	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—ABCA1—chronic kidney failure	0.00147	0.011	CbGpPWpGaD
Tyloxapol—LPL—Diseases associated with visual transduction—LRP2—chronic kidney failure	0.00136	0.0102	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—SCARB1—chronic kidney failure	0.00135	0.0101	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—SREBF1—chronic kidney failure	0.00131	0.00982	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—HMGCR—chronic kidney failure	0.00127	0.00955	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—FASN—chronic kidney failure	0.00125	0.00935	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—SREBF1—chronic kidney failure	0.0012	0.00899	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—CYP1A1—chronic kidney failure	0.00119	0.00892	CbGpPWpGaD
Tyloxapol—LPL—Lipoprotein metabolism—ALB—chronic kidney failure	0.00114	0.00854	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—chronic kidney failure	0.0011	0.00826	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—LPIN1—chronic kidney failure	0.00108	0.00813	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—NOS1—chronic kidney failure	0.00105	0.00785	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—SREBF1—chronic kidney failure	0.000788	0.00592	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—ALB—chronic kidney failure	0.000756	0.00568	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—RELA—chronic kidney failure	0.000728	0.00546	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—ADIPOQ—chronic kidney failure	0.000724	0.00543	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—PPARA—chronic kidney failure	0.00072	0.00541	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—PTGS2—chronic kidney failure	0.000707	0.00531	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—FABP1—chronic kidney failure	0.000654	0.00491	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—NFKB1—chronic kidney failure	0.000614	0.00461	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ACAT1—chronic kidney failure	0.000567	0.00425	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—VEGFA—chronic kidney failure	0.000557	0.00418	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—COL4A5—chronic kidney failure	0.00054	0.00405	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—NR3C1—chronic kidney failure	0.000506	0.00379	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—RELA—chronic kidney failure	0.000482	0.00362	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—TNF—chronic kidney failure	0.000478	0.00358	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—PPARA—chronic kidney failure	0.000474	0.00356	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—KRAS—chronic kidney failure	0.000474	0.00355	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ABCG1—chronic kidney failure	0.000448	0.00336	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIP5K1B—chronic kidney failure	0.000439	0.00329	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—IL1B—chronic kidney failure	0.000427	0.0032	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—LCAT—chronic kidney failure	0.000421	0.00316	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—NFKB1—chronic kidney failure	0.000407	0.00305	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IRS1—chronic kidney failure	0.000401	0.00301	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—COL4A3—chronic kidney failure	0.000399	0.00299	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SREBF2—chronic kidney failure	0.000394	0.00295	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MYH9—chronic kidney failure	0.00038	0.00285	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	0.000376	0.00282	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	0.000376	0.00282	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IGF1—chronic kidney failure	0.000372	0.00279	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—SERPINE1—chronic kidney failure	0.000353	0.00265	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	0.000352	0.00264	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	0.00034	0.00255	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—TGFB1—chronic kidney failure	0.000339	0.00254	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	0.000332	0.00249	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	0.000326	0.00244	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—TNF—chronic kidney failure	0.000316	0.00237	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TNF—chronic kidney failure	0.00031	0.00232	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—FABP1—chronic kidney failure	0.000291	0.00219	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	0.000277	0.00208	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AGXT—chronic kidney failure	0.000276	0.00207	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GATM—chronic kidney failure	0.000276	0.00207	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SREBF1—chronic kidney failure	0.000271	0.00203	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	0.00027	0.00202	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	0.00027	0.00202	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ACAT1—chronic kidney failure	0.000253	0.00189	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	0.000249	0.00187	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ADIPOQ—chronic kidney failure	0.000249	0.00187	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	0.000247	0.00185	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	0.000242	0.00182	CbGpPWpGaD
Tyloxapol—LPL—Disease—TFDP2—chronic kidney failure	0.000238	0.00179	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	0.000235	0.00177	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MLXIPL—chronic kidney failure	0.000235	0.00176	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIP5K1B—chronic kidney failure	0.000233	0.00175	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	0.00023	0.00173	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—TGFB1—chronic kidney failure	0.000223	0.00167	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC22A2—chronic kidney failure	0.000215	0.00161	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	0.00021	0.00157	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—TNF—chronic kidney failure	0.000208	0.00156	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCG1—chronic kidney failure	0.0002	0.0015	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIP5K1B—chronic kidney failure	0.000195	0.00147	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ARG2—chronic kidney failure	0.000191	0.00144	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LCAT—chronic kidney failure	0.000188	0.00141	CbGpPWpGaD
Tyloxapol—LPL—Disease—GCKR—chronic kidney failure	0.000181	0.00136	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—COL4A5—chronic kidney failure	0.00018	0.00135	CbGpPWpGaD
Tyloxapol—LPL—Disease—LRP2—chronic kidney failure	0.000173	0.0013	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—DDC—chronic kidney failure	0.000172	0.00129	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IL6—chronic kidney failure	0.000168	0.00126	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PRKD1—chronic kidney failure	0.000167	0.00126	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP2B6—chronic kidney failure	0.000167	0.00126	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PRKAG2—chronic kidney failure	0.000167	0.00126	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TFDP2—chronic kidney failure	0.000167	0.00125	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIP5K1B—chronic kidney failure	0.000163	0.00123	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PPARA—chronic kidney failure	0.000163	0.00122	CbGpPWpGaD
Tyloxapol—LPL—Disease—CYBB—chronic kidney failure	0.000161	0.00121	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	0.000159	0.00119	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SREBF2—chronic kidney failure	0.000157	0.00118	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGF23—chronic kidney failure	0.000152	0.00114	CbGpPWpGaD
Tyloxapol—LPL—Disease—CST3—chronic kidney failure	0.000152	0.00114	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCC3—chronic kidney failure	0.000151	0.00113	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GCKR—chronic kidney failure	0.000151	0.00113	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PGF—chronic kidney failure	0.000149	0.00112	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LPIN1—chronic kidney failure	0.000148	0.00111	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	0.000145	0.00109	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP2C18—chronic kidney failure	0.000145	0.00109	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LRP2—chronic kidney failure	0.000145	0.00109	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKAG2—chronic kidney failure	0.00014	0.00105	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—COL4A3—chronic kidney failure	0.000133	0.000995	CbGpPWpGaD
Tyloxapol—LPL—Disease—NCF1—chronic kidney failure	0.000133	0.000995	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CRHR1—chronic kidney failure	0.000126	0.000949	CbGpPWpGaD
Tyloxapol—LPL—Disease—CYBA—chronic kidney failure	0.000125	0.000935	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CPT1A—chronic kidney failure	0.000123	0.000925	CbGpPWpGaD
Tyloxapol—LPL—Disease—FASN—chronic kidney failure	0.000123	0.000919	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LRP2—chronic kidney failure	0.000121	0.00091	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP2C19—chronic kidney failure	0.00012	0.000902	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LIPC—chronic kidney failure	0.00012	0.000902	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	0.000119	0.00089	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTH—chronic kidney failure	0.000116	0.000868	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS1—chronic kidney failure	0.000115	0.000861	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CYBB—chronic kidney failure	0.000113	0.000846	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SCARB1—chronic kidney failure	0.000111	0.000833	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS1—chronic kidney failure	0.00011	0.000825	CbGpPWpGaD
Tyloxapol—LPL—Disease—HBEGF—chronic kidney failure	0.000109	0.000821	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RELA—chronic kidney failure	0.000109	0.000818	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	0.000108	0.000811	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SREBF1—chronic kidney failure	0.000108	0.000809	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGF23—chronic kidney failure	0.000107	0.000801	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HMGCR—chronic kidney failure	0.000105	0.000787	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—FASN—chronic kidney failure	0.000103	0.00077	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NPY—chronic kidney failure	0.0001	0.000754	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CRH—chronic kidney failure	9.69e-05	0.000727	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—OXT—chronic kidney failure	9.69e-05	0.000727	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP3A4—chronic kidney failure	9.51e-05	0.000713	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	9.46e-05	0.00071	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCA1—chronic kidney failure	9.35e-05	0.000701	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NCF1—chronic kidney failure	9.28e-05	0.000697	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NFKB1—chronic kidney failure	9.19e-05	0.00069	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NPS—chronic kidney failure	9.19e-05	0.00069	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DRD1—chronic kidney failure	9.01e-05	0.000676	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CYBA—chronic kidney failure	8.73e-05	0.000655	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—VEGFA—chronic kidney failure	8.34e-05	0.000626	CbGpPWpGaD
Tyloxapol—LPL—Disease—CCR5—chronic kidney failure	8.07e-05	0.000605	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CAT—chronic kidney failure	7.91e-05	0.000594	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTHFR—chronic kidney failure	7.88e-05	0.000592	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCB1—chronic kidney failure	7.7e-05	0.000577	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HBEGF—chronic kidney failure	7.66e-05	0.000575	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TGFB1—chronic kidney failure	7.66e-05	0.000574	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TNF—chronic kidney failure	7.15e-05	0.000536	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KRAS—chronic kidney failure	7.09e-05	0.000532	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP1A1—chronic kidney failure	7.08e-05	0.000531	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AVP—chronic kidney failure	6.64e-05	0.000499	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTHFR—chronic kidney failure	6.6e-05	0.000495	CbGpPWpGaD
Tyloxapol—LPL—Disease—IRS1—chronic kidney failure	6.55e-05	0.000491	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARA—chronic kidney failure	6.48e-05	0.000486	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EDN1—chronic kidney failure	6.32e-05	0.000474	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCL5—chronic kidney failure	6.27e-05	0.000471	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NGF—chronic kidney failure	5.81e-05	0.000436	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—IL6—chronic kidney failure	5.77e-05	0.000433	CbGpPWpGaD
Tyloxapol—LPL—Disease—SERPINE1—chronic kidney failure	5.76e-05	0.000432	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCR5—chronic kidney failure	5.65e-05	0.000424	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS3—chronic kidney failure	5.5e-05	0.000413	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—POMC—chronic kidney failure	5.28e-05	0.000396	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTGS2—chronic kidney failure	5.03e-05	0.000377	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—F2—chronic kidney failure	4.85e-05	0.000364	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALB—chronic kidney failure	4.81e-05	0.000361	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NOS3—chronic kidney failure	4.61e-05	0.000346	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IRS1—chronic kidney failure	4.59e-05	0.000344	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—POMC—chronic kidney failure	4.42e-05	0.000331	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCL2—chronic kidney failure	4.32e-05	0.000324	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF1—chronic kidney failure	4.25e-05	0.000319	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS2—chronic kidney failure	4.21e-05	0.000316	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SERPINE1—chronic kidney failure	4.03e-05	0.000303	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOS3—chronic kidney failure	3.85e-05	0.000289	CbGpPWpGaD
Tyloxapol—LPL—Disease—TGFB1—chronic kidney failure	3.64e-05	0.000273	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RELA—chronic kidney failure	3.62e-05	0.000272	CbGpPWpGaD
Tyloxapol—LPL—Disease—KRAS—chronic kidney failure	3.37e-05	0.000253	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NFKB1—chronic kidney failure	3.06e-05	0.000229	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFA—chronic kidney failure	2.77e-05	0.000208	CbGpPWpGaD
Tyloxapol—LPL—Disease—IL6—chronic kidney failure	2.74e-05	0.000206	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TGFB1—chronic kidney failure	2.55e-05	0.000191	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KRAS—chronic kidney failure	2.36e-05	0.000177	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL6—chronic kidney failure	1.92e-05	0.000144	CbGpPWpGaD
